NYPOZI 300 ug/300ug
filgrastim-txid · INJECTION · Cipla USA Inc.
No Recall History
Plain English
NYPOZI is a injection containing filgrastim-txid at 300 ug/300ug, taken intravenous. Manufactured by Cipla USA Inc..
Key Facts
- Brand Name
- NYPOZI
- Generic Name
- filgrastim-txid
- NDC Code (Product)
69097-430- Manufacturer
- Cipla USA Inc.
- Strength
- 300 ug/300ug
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761126
- Drug Class
- Leukocyte Growth Factor [EPC]
- Marketing Start
- 02/11/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is NYPOZI used for?
NYPOZI contains filgrastim-txid. It is a injection taken intravenous. Consult your doctor for specific uses.
Is NYPOZI a controlled substance?
NYPOZI is not classified as a controlled substance by the DEA.
What is the generic name for NYPOZI?
The generic name for NYPOZI is filgrastim-txid. There are 2 other brand versions of filgrastim-txid.
What is the NDC code for NYPOZI 300 ug/300ug?
The NDC (National Drug Code) for NYPOZI 300 ug/300ug is 69097-430, listed by Cipla USA Inc..